These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 1323930)
1. Circulating thrombomodulin as a novel endothelial cell marker: comparison of its behavior with von Willebrand factor and tissue-type plasminogen activator. Takahashi H; Ito S; Hanano M; Wada K; Niwano H; Seki Y; Shibata A Am J Hematol; 1992 Sep; 41(1):32-9. PubMed ID: 1323930 [TBL] [Abstract][Full Text] [Related]
2. Increased vascular endothelial cell markers in patients with disseminated intravascular coagulation. Wada H; Minamikawa K; Wakita Y; Nakase T; Kaneko T; Ohiwa M; Tamaki S; Deguchi K; Shirakawa S; Hayashi T Am J Hematol; 1993 Oct; 44(2):85-8. PubMed ID: 8266924 [TBL] [Abstract][Full Text] [Related]
4. Clinical significance of the venous occlusion test on systemic lupus erythematosus patients with a focus on changes in blood levels of tissue plasminogen activator, von Willebrand factor antigen, and thrombomodulin. Matsuda J; Kawasugi K; Gohchi K; Saitoh N; Tsukamoto M; Kazama M; Kinoshita T Acta Haematol; 1992; 88(1):22-6. PubMed ID: 1329422 [TBL] [Abstract][Full Text] [Related]
5. Increased levels of vascular endothelial cell markers in thrombotic thrombocytopenic purpura. Wada H; Kaneko T; Ohiwa M; Tanigawa M; Hayashi T; Tamaki S; Minami N; Deguchi K; Suzuki K; Nakano T Am J Hematol; 1993 Oct; 44(2):101-5. PubMed ID: 8266913 [TBL] [Abstract][Full Text] [Related]
7. Plasma thrombomodulin as a marker of vascular disorders in thrombotic thrombocytopenic purpura and disseminated intravascular coagulation. Wada H; Ohiwa M; Kaneko T; Tamaki S; Tanigawa M; Shirakawa S; Koyama M; Hayashi T; Suzuki K Am J Hematol; 1992 Jan; 39(1):20-4. PubMed ID: 1311143 [TBL] [Abstract][Full Text] [Related]
8. Biomarkers of endothelial dysfunction and outcomes in coronavirus disease 2019 (COVID-19) patients: A systematic review and meta-analysis. Andrianto ; Al-Farabi MJ; Nugraha RA; Marsudi BA; Azmi Y Microvasc Res; 2021 Nov; 138():104224. PubMed ID: 34273359 [TBL] [Abstract][Full Text] [Related]
9. [Thrombomodulin, von Willebrand factor and tissue plasminogen activator in the blood plasma of obese women and men]. Rość D; Drewniak W; Kinasz-Rózycka I; Kulwas A; Michalski A Pol Merkur Lekarski; 2003 Dec; 15(90):518-20. PubMed ID: 15058251 [TBL] [Abstract][Full Text] [Related]
10. Circulating thrombomodulin and hematological alterations in type 2 diabetic patients with retinopathy. Fujiwara Y; Tagami S; Kawakami Y J Atheroscler Thromb; 1998; 5(1):21-8. PubMed ID: 10077454 [TBL] [Abstract][Full Text] [Related]
11. Circulating thrombomodulin in thrombotic thrombocytopenic purpura. Takahashi H; Hanano M; Wada K; Tatewaki W; Niwano H; Tsubouchi J; Nakano M; Nakamura T; Shibata A Am J Hematol; 1991 Nov; 38(3):174-7. PubMed ID: 1659186 [TBL] [Abstract][Full Text] [Related]
12. Tissue factor pathway inhibitor and other endothelium-dependent hemostatic factors in elderly individuals with normal or impaired glucose tolerance and type 2 diabetes. Leurs PB; Stolk RP; Hamulyak K; Van Oerle R; Grobbee DE; Wolffenbuttel BH Diabetes Care; 2002 Aug; 25(8):1340-5. PubMed ID: 12145232 [TBL] [Abstract][Full Text] [Related]
14. In patients with deep-vein thrombosis elevated levels of factor VIII correlate only with von Willebrand factor but not other endothelial cell-derived coagulation and fibrinolysis proteins. Bombeli T; Jutzi M; De Conno E; Seifert B; Fehr J Blood Coagul Fibrinolysis; 2002 Oct; 13(7):577-81. PubMed ID: 12439142 [TBL] [Abstract][Full Text] [Related]
15. Tissue-type plasminogen activator and von Willebrand factor plasma levels as markers of endothelial involvement in patients with Raynaud's phenomenon. Marasini B; Cugno M; Bassani C; Stanzani M; Bottasso B; Agostoni A Int J Microcirc Clin Exp; 1992 Nov; 11(4):375-82. PubMed ID: 1459797 [TBL] [Abstract][Full Text] [Related]
16. Upregulation of pulmonary tissue factor, loss of thrombomodulin and immunothrombosis in SARS-CoV-2 infection. Francischetti IMB; Toomer K; Zhang Y; Jani J; Siddiqui Z; Brotman DJ; Hooper JE; Kickler TS EClinicalMedicine; 2021 Sep; 39():101069. PubMed ID: 34377969 [TBL] [Abstract][Full Text] [Related]
17. Aortic endothelial cell von Willebrand factor content, and circulating plasminogen activator inhibitor-1 are increased, but expression of endothelial leukocyte adhesion molecules is unchanged in insulin-dependent diabetic BB rats. Ribau JC; Samis JA; Senis YA; Maurice DH; Giles AR; DeReske M; Absher PM; Hatton MW; Richardson M Atherosclerosis; 2000 Apr; 149(2):331-42. PubMed ID: 10729383 [TBL] [Abstract][Full Text] [Related]
18. Plasma levels of soluble thrombomodulin increase in cases of disseminated intravascular coagulation with organ failure. Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Matsuda T Am J Hematol; 1991 Dec; 38(4):281-7. PubMed ID: 1660674 [TBL] [Abstract][Full Text] [Related]
19. Endothelial cell and hemostatic activation in relation to cytokines in patients with sepsis. López-Aguirre Y; Páramo JA Thromb Res; 1999 Apr; 94(2):95-101. PubMed ID: 10230894 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of plasma levels of thrombomodulin and von Willebrand factor in Egyptian children with acute lymphoblastic leukemia. Hagag AA; Abdel-Lateef AE; Aly R J Oncol Pharm Pract; 2014 Oct; 20(5):356-61. PubMed ID: 24243921 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]